Tina M Henkin

Title: Innovations and Contributions of Inventor Tina M Henkin

Introduction

Tina M Henkin is a notable inventor based in Dublin, OH (US). She has made significant contributions to the field of molecular biology, particularly in the development of assays and compounds that target RNA structures. With a total of 3 patents, her work has implications for antimicrobial research and RNA binding.

Latest Patents

Henkin's latest patents include innovative compositions that bind antiterminator RNA and assays for screening such compositions. One of her patents focuses on compounds that are selective binding agents specific for RNA secondary and tertiary structures. This includes a fluorescence assay for detecting the binding of small molecules to T-box antiterminator model mRNAs. The compounds developed in this patent feature novel tri-substituted oxazolidinones and amino alcohols. The assay provides fluorescently labeled model mRNAs that include conserved sequence information typical of antiterminator bulge regions found in the mRNA of T-box gene regulatory systems. Another significant patent involves an in vitro transcription assay for the T-box antitermination system. This method screens for antimicrobial agents that inhibit or disrupt the transcription of bacterial aminoacyl-tRNA synthetases, particularly in Gram-positive bacteria. The assay utilizes purified RNA polymerase and a template DNA fragment encoding glycyl-tRNA synthetase, allowing for the synthesis of RNA transcripts.

Career Highlights

Throughout her career, Henkin has worked with prestigious institutions such as Ohio University and The Ohio State University. Her research has contributed to advancements in understanding RNA interactions and the development of potential antimicrobial therapies.

Collaborations

Henkin has collaborated with notable colleagues, including Frank J Grundy and Jennifer V Hines. These partnerships have enhanced her research and expanded the impact of her inventions.

Conclusion

Tina M Henkin's innovative work in RNA research and antimicrobial assays showcases her significant contributions to the scientific community. Her patents reflect a commitment to advancing molecular biology and addressing critical health challenges.